Khiron Life Sciences Balance Sheet Health
Financial Health criteria checks 3/6
Khiron Life Sciences has a total shareholder equity of CA$27.1M and total debt of CA$816.0K, which brings its debt-to-equity ratio to 3%. Its total assets and total liabilities are CA$38.5M and CA$11.3M respectively.
Key information
3.0%
Debt to equity ratio
CA$816.00k
Debt
Interest coverage ratio | n/a |
Cash | CA$1.94m |
Equity | CA$27.10m |
Total liabilities | CA$11.35m |
Total assets | CA$38.45m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4KH's short term assets (CA$18.3M) exceed its short term liabilities (CA$9.1M).
Long Term Liabilities: 4KH's short term assets (CA$18.3M) exceed its long term liabilities (CA$2.3M).
Debt to Equity History and Analysis
Debt Level: 4KH has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 4KH's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 4KH has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 4KH has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.